This company develops technology and services to extend the safe preservation times for donor kidneys. They utilize warm normothermic preservation to keep rescued kidneys viable longer, allowing for more informed surgical decisions. Their goal is to reduce the number of kidneys discarded and patients lost from the transplant waiting list.
Funding
$44M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Each year, thousands of kidneys intended for transplant go unused due to limitations in preservation techniques and logistical constraints, contributing to patient mortality on transplant waiting lists. Current preservation methods often fail to maintain organ viability for extended periods, leading to discard rates and missed transplant opportunities.
Solution
34 Lives is developing normothermic preservation technology to extend the viability of unused kidneys, increasing the window of opportunity for successful transplantation. Their approach involves rescuing and maintaining kidneys in a warm, metabolically active state, thus prolonging their safe out-of-body time. By providing detailed assessment data on each kidney, 34 Lives aims to facilitate more informed decision-making and improve transplant outcomes. The goal is to reduce the number of patients who are removed from transplant waiting lists due to death or deteriorating health.
Target Audience
The primary customers are organ procurement organizations (OPOs) and transplant surgeons seeking to improve kidney preservation and increase the utilization of available organs.
Features
- Normothermic preservation system designed to maintain kidney viability outside the body.
- Detailed kidney assessment and data collection to aid transplant surgeons.
- Technology aimed at safely doubling current kidney preservation times.